Katherine Ann  Owen net worth and biography

Katherine Owen Biography and Net Worth

VP of Stryker
Katherine A. Owen joined Stryker as Vice President, Strategy and Investor Relations, in February 2007. Ms. Owen is responsible for overseeing the strategic planning and business development processes at Stryker, as well as investor relations.

Prior to joining Stryker, Ms. Owen served as a Medical Technology Analyst at Merrill Lynch. Shepreviously served as a Medical Technology Analyst at Cowen & Co./SG Cowen. She also was a Corporate Lending Analyst at State Street Bank and an Underwriter at Chubb Insurance Corporation.
Ms. Owen holds a B.A. in Economics from the University of Massachusetts at Amherst and a M.B.A. from Boston College.

What is Katherine Ann Owen's net worth?

The estimated net worth of Katherine Ann Owen is at least $1.73 million as of May 7th, 2020. Ms. Owen owns 4,481 shares of Stryker stock worth more than $1,728,232 as of November 21st. This net worth approximation does not reflect any other investments that Ms. Owen may own. Learn More about Katherine Ann Owen's net worth.

How do I contact Katherine Ann Owen?

The corporate mailing address for Ms. Owen and other Stryker executives is 2825 AIRVIEW BLVD, KALAMAZOO MI, 49002. Stryker can also be reached via phone at (269) 385-2600 and via email at [email protected]. Learn More on Katherine Ann Owen's contact information.

Has Katherine Ann Owen been buying or selling shares of Stryker?

Katherine Ann Owen has not been actively trading shares of Stryker within the last three months. Most recently, Katherine Ann Owen sold 3,121 shares of the business's stock in a transaction on Thursday, May 7th. The shares were sold at an average price of $190.81, for a transaction totalling $595,518.01. Following the completion of the sale, the vice president now directly owns 4,481 shares of the company's stock, valued at $855,019.61. Learn More on Katherine Ann Owen's trading history.

Who are Stryker's active insiders?

Stryker's insider roster includes Yin Becker (VP), William Berry, Jr. (VP), Glenn Boehnlein (CFO), Srikant Datar (Director), Roch Doliveux (Director), M. Fink (VP), Robert Fletcher (VP), Allan Golston (Director), Kevin Lobo (CEO), Katherine Owen (VP), James Pierce (Insider), Bijoy Sagar (VP), Timothy Scannell (COO), and Ronda Stryker (Director). Learn More on Stryker's active insiders.

Are insiders buying or selling shares of Stryker?

In the last year, insiders at the medical technology company sold shares 10 times. They sold a total of 490,063 shares worth more than $165,955,919.20. The most recent insider tranaction occured on November, 7th when CEO Kevin Lobo sold 57,313 shares worth more than $21,131,303.10. Insiders at Stryker own 5.9% of the company. Learn More about insider trades at Stryker.

Information on this page was last updated on 11/7/2024.

Katherine Ann Owen Insider Trading History at Stryker

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/7/2020Sell3,121$190.81$595,518.014,481View SEC Filing Icon  
5/5/2020Sell9,149$186.79$1,708,941.711,085View SEC Filing Icon  
9/26/2019Sell2,500$216.30$540,750.005,349View SEC Filing Icon  
3/8/2019Sell29,247$185.62$5,428,828.1411,131View SEC Filing Icon  
9/5/2018Sell37,866$166.84$6,317,563.4411,367View SEC Filing Icon  
4/18/2018Sell2,651$165.00$437,415.007,729View SEC Filing Icon  
3/26/2018Sell103$160.00$16,480.0010,380View SEC Filing Icon  
3/5/2018Sell3,700$161.66$598,142.007,596View SEC Filing Icon  
7/5/2016Sell6,674$121.21$808,955.5410,753View SEC Filing Icon  
7/1/2016Sell10,686$120.05$1,282,854.3013,593View SEC Filing Icon  
4/4/2016Sell10,914$109.29$1,192,791.0628,715View SEC Filing Icon  
12/31/2015Sell12,144$93.45$1,134,856.8013,593View SEC Filing Icon  
7/24/2015Sell6,505$100.05$650,825.25View SEC Filing Icon  
5/4/2015Sell18,575$93.82$1,742,706.50View SEC Filing Icon  
12/22/2014Sell30,000$94.84$2,845,200.00View SEC Filing Icon  
8/4/2014Sell20,625$80.25$1,655,156.25View SEC Filing Icon  
8/1/2014Sell35,000$79.97$2,798,950.00View SEC Filing Icon  
6/3/2014Sell15,000$84.63$1,269,450.00View SEC Filing Icon  
See Full Table

Katherine Ann Owen Buying and Selling Activity at Stryker

This chart shows Katherine Ann Owen's buying and selling at Stryker by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Stryker Company Overview

Stryker logo
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.
Read More

Today's Range

Now: $386.76
Low: $384.57
High: $387.38

50 Day Range

MA: $365.46
Low: $345.14
High: $390.08

2 Week Range

Now: $386.76
Low: $285.79
High: $398.20

Volume

44,709 shs

Average Volume

1,265,157 shs

Market Capitalization

$147.44 billion

P/E Ratio

41.45

Dividend Yield

0.82%

Beta

0.91